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Sex Med 2Introduction: Rodent animal models are currently the most used in vivo model in translational studies looking
into the pathophysiology of erectile dysfunction after nerve-sparing radical prostatectomy.
Aim: This European Society for Sexual Medicine (ESSM) statement aims to guide scientists toward utilization of
the rodent model in an appropriate, timely, and proficient fashion.
Methods: MEDLINE and EMBASE databases were searched for basic science studies, using a rodent animal
model, looking into the consequence of pelvic nerve injury on erectile function.
Main outcome measures: The authors present a consensus on how to best perform experiments with this
rodent model, the details of the technique, and highlight possible pitfalls.
Results: Owing to the specific issue—basic science—Oxford 2011 Levels of Evidence criteria cannot be applied.
However, ESSM statements on this topic will be provided in which we summarize the ESSM position on various
aspects of the model such as the use of the Animal Research Reporting In Vivo Experiments guideline and the of
common range parameter for nerve stimulation. We also highlighted the translational limits of the model.
Conclusion: The following statements were formulated as a suggestive guidance for scientists using the
cavernous nerve injury model. With this, we hope to standardize and further improve the quality of research in
this field. It must be noted that this model has its limitations. Weyne E, Ilg MM, Cakir OO, et al. European
Society for Sexual Medicine Consensus Statement on the Use of the Cavernous Nerve Injury Rodent Model
to Study Postradical Prostatectomy Erectile Dysfunction. Sex Med 2020;XX:XXXeXXX.
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2 Weyne et alINTRODUCTION
The advent of prostate specific antigen screening has led to the
early detection of prostate cancer (PCa). As a conclusion, more
and more patients will have good long-term oncologic outcome
after radical prostatectomy (RP).1e3 In contrast, it has been re-
ported that only 23% of men younger than 60 years regain their
complete erectile function (EF) after bilateral nerve-sparing RP
(NSRP).4
In accordance with the most recent literature,5 patient pre-
operative and intraoperative factors (including age, preoperative
EF, comorbidities), type of surgery (unilateral vs bilateral nerve-
sparing), grade of nerve sparing (ie, intrafascial vs interfascial vs
extrafascial surgeries), and surgical skill represent the key signif-
icant contributors to EF recovery after NSRP.5
In nerve-sparing surgery, erectile dysfunction (ED) occurs as a
consequence of iatrogenic damage to the periprostatic neuro-
vascular bundle, which results in neuropraxia of the cavernous
nerves (CNs).5e9 Neurapraxia, as per the Seddon classification, is
a temporary failure of nerve conduction because of a damage to
the myelin sheath.10,11 The Seddon classification of nerve injury
separates injury based on the scale from microscopic to macro-
scopic along with severity of tissue injury, prognosis, and time for
recovery. Seddon described 3 types of nerve injury—neurapraxia,
axonotmesis, and neurotmesis12 with each type having a different
potential for regeneration. Neurapraxia, the temporary block of
the CN conduction, results in a decrease of the rate and quality
of both daily and nocturnal erections, and it promotes a persis-
tent cavernous hypoxia.10,11 In vitro and in vivo studies sug-
gested that the neurapraxia and the consequent penile hypoxia
might result in collagen accumulation, smooth-muscle apoptosis,
and fibrosis.13,14
Finally, these penile changes lead to venous leakage and per-
manent ED before complete recovery of the nerve integrity can
be achieved up to 2 years after surgery.15 It has been shown that
ED occurring after RP differs from classical vasculogenic
ED.16e19 In human corpus cavernosum tissue, endothelial
function was preserved in patients after RP, whereas significant
disturbances were seen in neurogenic relaxation with sympathetic
hyper innervation. Accordingly, molecular analysis of protein
expression showed significant changes of neuronal proteins in
post-RP ED which differs from that observed in vasculogenic
ED.16 In line to what is observed in humans, it was reported that
penile endothelial function was preserved in rats after crushing of
the CNs.18,19 In contrast, imbalanced neurogenic responses fa-
voring adrenergic contraction over nitrergic relaxations have been
observed in the human tissue and rat model.17,19 This concept is
very important because recovery of endothelial function has been
used as an end point in many interventional studies in rats
investigating therapeutics in post-RP ED.20
Animal models mimicking this CN injury (CNI) have played
a role in the advancement of the field.21,22 Rodent models have
become the standard in early phases of in vivo research methodbecause of their relatively low cost compared with other animal
species.21e23 Both mouse and rat animal models are available,
with mice potentially allowing higher throughput in some cases,
while also providing options for genetic knockout or modifica-
tion.24 However, despite the possibility of genetic engineering
providing a valuable tool for investigation, evaluation of EF may
be more challenging in the mouse than in the rat model.25Va-
rious preclinical studies, using NSRP rodent models, have
demonstrated that vacuum erection devices and several medica-
tions (ie, alprostadil injections, phosphodiesterase type 5 in-
hibitors, and so on) are able to promote EF recovery, improve the
cavernosal smooth-muscle/collagen ratio, increase penile smooth-
muscle replication, reduce penile apoptosis, preserve penile
endothelial function, increase antioxidant enzymes, and promote
neuroprotection during and after neuropraxia.22
In spite of promising results generated in the rodent models,
most of the well-designed clinical trials have failed to confirm any
structural or lasting benefit of this type of treatment in improving
the recovery of EF after RP.5,7,8,26e28
One of the reasons for the discrepancy between the clinical
and animal data may be because of variance in the methodology
used when conducting the basic science studies.22 The variance
in the methodology and the lack of consensus guidelines for the
use of the NSRP rat model (also called bilateral CN crush,
transection, excision, dissection, freezing, electrocautery, and
irradiation model) have led to the publication of studies whose
results are often equivocal and impossible to compare.29
The aim of this review is to review the current state of art,
highlight possible pitfalls, and provide statements for experi-
mental technique and reporting in the use of the NSRP rat
model; to provide further standardization and improvement in
the quality of research in this field on behalf of the European
Society of Sexual Medicine (ESSM).METHODS
MEDLINE and EMBASE databases were searched for articles
looking with the following search terms: (“erectile dysfunction”
OR “erectile function”OR “radical prostatectomy”OR “post-RP
ED” OR “cavernous nerve injury”) AND (“animal model” OR
“model”). Studies from 1980 up to 2019 were included.
Abstracts were screened for relevance (F.C. and E.W.); if it
was not clear from the abstract whether the article may contain
relevant data, the full article was assessed.
Only the basic science studies, using a rodent animal model,
looking into the consequence of pelvic nerve injury on EF were
considered relevant for this study. Thereafter, relevant studies were
analyzed and summarized after an interactive peer-review process of
the panel (F.C., E.W., D.B.R., M.I., A.M., and C.G.) to obtain a
narrative review. The statements were internally discussed. Dis-
agreements were resolved by consensus. The study was internally
reviewed by senior authors (M.A., C.B., Y.C., J.A.).Sex Med 2020;-:1e11
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Levels of Evidence criteria cannot be applied. However, ESSM
statements on this topic will be provided in which we summarize
the ESSM position on various aspects of the model.
Ethical board approval was not required for this work.GENERAL CONCEPTS OF TRANSLATIONAL
RESEARCH—THE ANIMAL RESEARCH REPORTING
IN VIVO EXPERIMENTS GUIDELINE
Statement #1: The ARRIVE check list should be completed
and submitted with the manuscript. In particular, the strain, sex,
weight, and age of animals always needs to be reported.Evidence
The initial basis for addressing a clinical problem in an
experimental setting is the selection of a valid model that cor-
responds to the human condition in etiology, pathophysiology,
symptomatology, and response to therapeutic interventions.
The key to using any method or model is to understand its
limits and what outcomes it measures, represents, and is able to
forecast. For animal models, comparable biological processes or
behaviors to signs, responses, or symptoms of human functions
and disease, that is face validity, are important for translational
research.30 In sexual arousal, penile erection is an example of a
component of male sexual behavior that in several species share
substantial physiological and biochemical events and for which
methods exist that can be used to assess similar end points.31e35
Human clinical trials are regulated by authorities to reduce biases
by patients and investigators, whereas corresponding controls do
not seem to be extensively in effect in medical research with
animals, that despite more objective end points, still is at risk for
unconscious procedural errors.36 To increase the value of
research processes with animals, we emphasize the concept that
the ARRIVE (Animal Research Reporting In Vivo Experiments)
guidelines and recommendations should be followed.25 In
particular, the ARRIVE guidelines were developed to improve
standards of reporting and ensure that the data from animal
experiments can be fully evaluated and used. They consist of a
20-point checklist (https://www.nc3rs.org.uk/sites/default/files/
documents/Guidelines/NC3Rs%20ARRIVE%20Guidelines%
20Checklist%20(fillable).pdf) of the essential information that
should be included in publications reporting animal research. No
study has so far examined how authors of publications involving
CNI in rodent models adhered to the ARRIVE guidelines.
However, there is a recent survey of 271 publications between
1999 and 2005, which involved the use of live rats, mice, and
non-human primates, carried out in the UK and US publicly
funded research establishments. This survey provided evidence
that many peer-reviewed, animal research publications fail to
report important information regarding animal demographics
and experimental protocols.37 To mention some examples from
this survey, 24% of studies did neither report the age nor theSex Med 2020;-:1e11weight of animals, 12% of studies reported random allocation of
animals to groups, 5.9% used investigator blinding to treatment,
and in 4% of the studies, the statistical method was unclear.37Remarks
Similar potential deficiencies in animal research are noted in
several medical areas, including sexual medicine, and correlations
have been made between insufficient reporting and translational
value.36 Few articles in the sexual medicine field have reported
the use of the ARRIVE checklist.38e41This concept is very
important because similar to humans, several mammals
display —in aging or because of various diseases—signs of ED
and alterations of important regulatory pathways of erection.24
The lack of crucial information can prevent the correct evalua-
tion of the final results obtained. The ARRIVE checklist should
be completed and submitted with the manuscript involving
animal models for radical retropubic prostatectomy.PHYSIOLOGICAL INVESTIGATIONS OF PENILE
ERECTION—THE RAT ANIMAL MODEL
Extensive research suggests that regulatory mechanisms of
penile erection exhibit substantial physiological, biochemical,
and pharmacologic homologies among mammalian species,
including humans.31e33 For example, human, monkey, rabbit,
dog, rat, and mouse corpus cavernosum tissue that is precon-
tracted to simulate penile flaccidity responds similarly via
neuronal and endothelial signals with relevant nitric oxide
(NO)-dependent relaxant “erection-simulating” responses.42e47
Accordingly, a crucial role for the nitric oxide pathway in
penile erection has been characterized in vivo during erections in
various animals.38,48e52 However, peculiar species characteristics
are also present. Hence, the selection of the correct animal model
and the parameters to be tested is essential in transitional med-
icine (see the following sections).Measurement of Intracavernous and Corpus
Spongiosum Pressure
Statement #2: The use of intracavernous pressure (ICP) reg-
istrations should be preferred to corpus spongiosum pressure
(CSP) as an end point during erection.
Statement #3: The Methods section should clearly report if
ICP or CSP was recorded.Evidence
The human corpus spongiosum is responsible for engorge-
ment of the glans during the erection. The human bulbo-
spongiosus muscle that surrounded the corpus spongiosum has
an important role to propel semen during the expulsion phase of
ejaculation.53e56 In rats that have a peculiar anatomy of the
penis with an almost 180 frontal flex of the glans, penile striated
muscle activity is also essential to compress the erectile
compartment to straighten the glans penis (“flips”) to achieve
4 Weyne et alintromission.57 After transection of the CN, the rat can still
achieve erections of the glans.57 Furthermore, in contrast to
humans, rats also use the bulbospongiosus muscle together with
a well-developed rhabdosphincter to forcefully and rhythmically
expel urine during micturition.58e60 Consequently, significant
pressure responses are recorded during rat micturition, and
therefore, for the use of CSP registration in awake and freely
moving rats, the behavioral context may need particular
attention.60Remarks
Some investigators have studied CSP as an end point during
erection.61e63 When compared with the corpora cavernosa, the
corpus spongiosum has a less-firm tunica albuginea and arterio-
venous shunts in the glans and may be considered to be a flow-
through compartment with lower pressures during erection.64,65
Owing to this potential bias, the use of ICP registrations should
be preferred to CSP as an endpoint during erection.ICP and Mean Arterial Pressure
Statement #4: ICP should be normalized by mean arterial
blood pressure (MAP); especially when vasoactive substances are
used.
Statement #5: Detailed description of the method used to
record ICP and MAP should be reported.
Statement #6: Exemplary and representative images of the ICP
and MAP traces should be included in or attached to the
manuscript.
Evidence
Activation of the pelvic nerve or the cavernous (penile) nerve
by contact electrodes has been shown to induce analogous penile
erections in monkeys, dogs, rabbits, rats, and mice that are
recorded as characteristic changes in ICP.66e69 Correspondingly,
in patients undergoing NSRP or penile surgery, stimulation of
the neurovascular bundle posterolateral to the prostate induced
subjectively assessed erections or penile tumescence, and activa-
tion of the CNs similarly caused visible erections that were
correlated to simultaneous increases in ICP.65,70 Hence, under
these investigative conditions, techniques to study nerve-induced
increases in ICP in animals seem to comprise appropriate
translational models for humans.
ICP measurement in rodent can be achieved by implanting
the tip of a recording catheter into the corpus cavernosum and
connecting to a pressure transducer.62
To register ICP responses, commonly either the crura or the
body of the corpus cavernosum is cannulated using either PE
tubes or needles. However, few studies exist that compare the
cannulation sites.71 The insertion of the catheter can be per-
formed using a small needle connected to the end of the
recording catheter or via an incision of the tunica albuginea of
the penis, fixing it with a purse-string suture. Before and after theinsertion the catheter and the needle, if used, should be flushed
with a solution containing heparin to avoid clots. There are no
studies that have investigated differences in the outline of the
experimental setup. To register systemic blood pressure, a large
artery, commonly the aorta or the carotid artery, is cannulated
using either PE tubes or needles filled with heparin.72Remarks
Because arterial blood pressure may affect ICP responses, a
standard experimental setup should include procedures for
simultaneous recording of pressures from the erectile compart-
ment and central arteries.73 Consequently, the amplitude and/or
area under curve of the erectile responses after electrical stimu-
lation of the CN should be normalized by the MAP during the
erectile response and reported as such.64 As ICP can be affected
by hemodynamics, it is highly recommended that the ICP is
adjusted by the MAP and reported as ICP/MAP especially when
vasoactive substance are used.73 Exemplary traces of ICP and
MAP are usually included in the manuscript as to provide the
reader and reviewers with the option of assessing quality of
registration/stimulation.74
The authors should clearly report and describe the measures
recorded during the experiment. These should include how
many electrical stimulations were performed for each animal, the
length of electrical stimulation, and if ICP mean or peak is used
in the calculation. The authors should also clearly report the
methodology and the instruments that were used during the
experiment including: the site of (crura or corpora) the catheter
insertion, the size and the material of the catheters used, the size
of the needle used, the amount and the concentration of heparin
that was administrated, and the instrument used for the crush
and for how long the crush was performed. The version of
recording machine and software used should be accurately
described.Type of Rodent Models
Statement #7: Rodent models should be used to mimic post-
RP ED. While mouse models might offer higher throughput and
options for genetic modification, rat models might offer more
ease of use for CN stimulation.
Evidence
The rat is the most commonly used species for in vivo studies
of erection. Electrical stimulation of the CN can cause repro-
ducible ICP responses after appropriate training.29,33,75 The rat
bilaterally has a single CN that is readily identified running from
the pelvic ganglion on the lateral side of the prostate (Figure 1),
whereas corresponding structures in humans are derived from a
more diffuse nervous meshwork of the neurovascular
bundle.75e77 Behavioral, neurophysiological, and molecular
biological or genetic procedures are conveniently available for
multimodal investigations when using rats, and animal purchase,
housing, and maintenance costs are relatively low. While miceSex Med 2020;-:1e11
Figure 1. Rat cavernous nerve stimulation. CN ¼ cavernous nerve;
MPG ¼ major pelvic ganglion.
ESSM Statement on the Rodent Radical Retropubic Prostatectomy Model 5might offer a higher experimental throughput in some cases, the
CN stimulation as well as the ICP recording might be easily
achieved in the rat model.33,78 It should be noted that the rat is
reported to exhibit ancillary penile innervation from the major
pelvic ganglion, which accounts for around 45% of ICP re-
sponses to supraspinal stimuli after CN transection.76 These
ancillary nerves are not damaged in the rat model of RP.
Remark
The lack of damage to these ancillary nerves represents an
element to be considered in the design of the experiment rep-
resenting a possible source of bias. However, there are no studies
that have tested the long-term effect of the ancillary nerves on the
EF of the rat.Parameters for CN Electrical Stimulation
Statement #8: Detailed description of the parameters for CN
electrical stimulation, including: pulse duration, frequency,
duration of stimulation, voltage and rest period, should be
reported.
Statement #9: The most commonly agreed parameter ranges
for cavernous nerve stimulation in rats are pulse duration,
0.5 mse1 ms, frequency, 10e20 Hz; duration of stimulation,
30e60 seconds; voltage, 2.5e8V (L4). Frequency- or voltage-
response curves should be established to manifest optimal and
suboptimal stimulation parameters. Rest periods of at least
5e10 minutes between subsequent stimulations should be
applied. We recommend using these parameters to improve
comparability between studies.
Evidence
Most researchers have reported the stimulus in volts and values
ranged from 1 to 15V.75,79e81,71,82,83 Other groups have reported
the intensity of the current (ampere) for characterizing the pro-
cedure of nerve activation, and this parameter ranged between
0.5e10 mA.71,84e86 The frequencies (Hertz) of the stimuli used
by the aforementioned research groups varied between 1 andSex Med 2020;-:1e1130 Hz. Optimal (maximal) ICP responses are generally reported
around 6e7.5 V or 1.5 mA and between 10 and 20 Hz.79,71,84,87
Ideally, a voltage-response or intensity-response or frequency-
response curve is produced to depict erectile responses elicited at
several electrical stimulation parameters as this may yield inter-
esting information on the erectile effect a compound/device may
produce (at low-, intermediate-, or high-stimulation parameters).
Another parameter of interest for nerve stimulation is the width
(or duration) of the single pulse to differentiate the threshold for
activation of different types of nerves.88 This parameter is reported
to vary from 0.05 to 5 ms.80,81,71,84e87,89 Considering settings for
optimal stimulation of the vagus nerve in rats, CN activation in
dogs, or these used for intraoperative activation of the CN in
humans, a pulse width around 0.2 ms is probably appropriate for
rodent ICP models.65,90e93 In the mouse ICP model, 0.5e6V,
5e20 Hz, and pulse durations of 1e5 ms have been used to
activate the CN.66,94 Maximal ICP responses were reported at 3V
and 15 Hz.66
Remarks
A quite high variability of electrical stimulation parameters used
by different research groups has been reported. This may in part be
related to the type of stimulators used whether the voltage or the
current can be regulated. For voltage stimulators, the resistance of
the electrode may affect the intensity of the current needed to
activate the nerve. Conversely, stimulators that adjust for the
resistance in the electrode delivers stable currents for nerve activa-
tion.65 We recommend using the most commonly used parameters
(outlined previously) to improve comparability between studies.Site for CN Electrical Stimulation
Statement #10: The author should clearly report if a unilateral
or bilateral CN stimulation were performed.
Statement #11: The author should clearly report the location
of nerve stimulation that is proximally or distal to the point of
the nerve damage.Evidence
Recording erections with a video camera, Quinlan et al 75
observed better responses upon bilateral stimulation of the CN as
compared with unilateral nerve activation. Even so, most of the
following studies have implemented unilateral stimulation of the
CN, and it may be discussed if the neurovascular mechanisms
responsible for ICP responses are fully activated under such con-
ditions, hence the advantage of performing a response curve to
several electrical stimulation parameters to reach maximal response.
As reported by registration of ICP in dogs, unilateral stimulation of
the CN induced full erection of both the corpora cavernosa even if
the ICP responses were achieved faster by bilateral stimulation.91
Remarks
Unilateral CN stimulation may give false low-filling values for
tumescence and possibly display a delayed onset of the veno-
Table 1. Methods of rat nerve injury
Method of nerve injury Comment Details Reference
Crush CN injury Resembling nerve sparing RP Crushing CN by applying instrument distal of
MPG (eg, forceps 3  15 seconds or
hemostat 3 minutes).
5
Excision CN injury Resembling non-nerve sparing RP Segment of CN is removed, resulting in a gap
between nerve endings.
92
Transection CN injury Resembling non-nerve sparing RP Division of CN, nerve endings remain
close by.
95
Unilateral nerve injury Nerve sprouting and maintenance of
erections from contralateral side are
disadvantages
1 CN injured, other unharmed. 70
Bilateral nerve injury Considered to be the gold standard and most
reliable to study erectile function recovery
Both CN are injured. 70
Stretching injury Difficult to standardize Nerve is dissected and held under traction. 96
Freezing injury Unnatural method of injury CN is frozen with contact to dry ice or
thermocoupling probe.
32
Dissecting injury Difficult to standardize CN is dissected around the prostate and
isolated without deliberately injuring.
33
CN ¼ cavernous nerve; MPG ¼ major pelvic ganglion; RP ¼ radical prostatectomy.
6 Weyne et alocclusive mechanisms. It must be noted, however, that most of the
studies currently performed in rats use unilateral nerve stimula-
tion. The unilateral CNI model can serve as its own control; the
injured and sham groups are in the same animal at the same time,
while having the disadvantage of potential compensatory action of
the intact nerve. More importantly, the location of nerve stimu-
lation that is proximally or distal to the point of nerve damage
nerve damage could influence the ICP response. An electrical
stimulation proximal to the point of nerve damage evaluates both
the component of nerve damage and those of damage to erectile
tissue. Distal nerve damage stimulation evaluates only the
component of erectile tissue by bypassing nerve damage.Type of CNI
Statement #12: Bilateral and not unilateral CNI should be
considered as the standard animal model for human RP.
Statement #13: Detailed description of the parameters for
CNI including mode of injury (crush, transection, cold, heat,),
type of instrument used, and duration of injury and should be
reported for the purpose of reproducibility of the model.Evidence
Both unilateral and bilateral CNI models have been used to
study ED and are believed to imitate the condition in humans
after RP. Various types of CNI have been studied in rodent
models, especially rats.78 These models were stratified by the type
and extent of injury. Various types of injury techniques such as
stretching, crushing, freezing, transecting, dissecting, and excising
the CN as well as unilateral vs bilateral CNI have been described22
(Table 1). Crushing of CNs is most commonly used to mimic the
nerve injury that occurs when using the NSRP technique.22 On
the other hand, transection and excision of the CNs are mostlyused to mimic RP without nerve-sparing procedure.29 The crush
injury model involves various mechanical compressions of the CN
over varying periods of compression time.6,26,72,95 The crushing
can be induced by several instruments (forceps, hemostatic, or
bulldog clamps, microserrefine serrated or not).It is not clear if the
instrument used or the timing of the crush can induce any dif-
ference in the magnitude and consistency of provoked ED.71
Transection injury consists of direct division of the CN,
whereas excision CNI implicates the removal of a segment of
CN.96 CNI can be applied unilaterally or bilaterally.
Remarks
In unilateral nerve injury models, mimicking unilateral NSRP,
the nerve supply is partly preserved and therefore penile elections
partly maintained.76 Furthermore, compensatory nerve sprouting
from the intact contralateral CN is believed to occur.10 In uni-
lateral injury models, the contralateral side is often used as a
control, but as mentioned, contralateral sprouting can confound
experimental interpretation.10 Because of these reasons, bilateral
and not unilateral CNI is considered as the standard model.22,78Limitations
Statement #14: Rodent models for erectile dysfunction after
NSRP used in experimental studies present important limitations
when compared with the clinical settings. These limitations
should be reported.
Statement #15: The author should consider a possible source
of discrepancy between basic science studies and the clinical
practice. The limitations are as follows: the age of the rat involved
in the experiment, the absence of rat comorbidities, and the
spontaneous recovery of erectile function of the rat after
6 months.Sex Med 2020;-:1e11
ESSM Statement on the Rodent Radical Retropubic Prostatectomy Model 7Evidence
For rat animal studies, male rats between the age of 10 and
12 weeks or weighing between 300 and 400 grams are generally
used.29,22 It has been criticized that the age of these rats corre-
sponds with adolescence in humans and not middle-aged men
such as typically seen in patients with PCa .97 Days or months
after the CN injuries, the EF is evaluated as per the Quinlan
et al75 model by the electrical stimulation of the injured nerve.98
In rodent studies, the exact time frame in which maximal nerve
regeneration and EF recovery occurs is not uniformly agreed
upon. Commonly, EF is evaluated 4 weeks after nerve injury in
rats because it is generally believed to represent the 2-year time in
humans.99 Indeed, in humans, EF continues to improve up to
24 months after RP.100 As early as 1 day and up to a week after
CN crush, only 30e40% of axons survive and maximal ICP
response to CN stimulation are 4 times lower than in control
animals.101,102 It has been shown that EF is decreased 48 hours
after bilateral crush CNI and starts to recover at 60 days after
injury.103 Spontaneous complete recovery of EF has been seen
6 months after bilateral CN crush injury after injury.104
Rodent models have been used to study pathophysiologic
mechanisms and assorted pharmacologic, surgical, and regener-
ative treatments.22 Several preclinical and translational studies
have shown a benefit of penile rehabilitation therapies such as
phosphodiesterase type 5 inhibitor/GC activator treatment,105
immunomodulation, neurotrophic factor administration, and
regenerative medicine options such as stem cell therapy in ani-
mals.22 However, most of these approaches have either failed
clinical translation or have yet to be studied in human subjects.11Remarks
The reason of these clinical translation failures may lie in the
limits that characterize the CNI model and in the design bias
which can occur in basic science studies:
1) The EF evaluation in rats is performed by an objective
method (ICP evaluation, electrical stimulation of CN) and,
on the other hand, in the clinical practice the evaluation is
performed via questionnaires.11
2) As mentioned, there are reports that the ancillary nerves
provide more than 50% of the proerectile innervation to the
rat penis.76 These ancillary nerves remain unaffected in the
CNI model, and it is unclear if this might have an impact on
the severity of ED in rats compared with humans. More
important, the CNI mimics a “perfect “bilateral intrafacial
nerve-sparing procedure difficult to perform in all the patients
in the clinical setting.
3) The CNI studies, commonly use 10- to 12-week-old and thus
healthy young rats without any baseline ED.29,22 This does
not reflect the current clinical landscape. Patients with PCa
are commonly older than 50 years of age and may be suffering
from different comorbidities (diabetes, cardiovascular disease)
which cause baseline ED and can impair nerve repair mech-
anisms after the NSRP.15 This discrepancy between basicSex Med 2020;-:1e11science studies and the clinical practice is illustrated in several
clinical studies which showed that young patients without
comorbidities have a better recovery of EF after NSRP
compared with other patients.5,8,106 Moreover, preoperative
EF and Carlson Comorbidity Index are considered indepen-
dent predictors for EF recovery.15
4) The spontaneous recovery of EF in the CNI rat model104 has
important scientific-translational consequences. Indeed, this
model can only be used to assess if a treatment can modify the
time to return of EF recovery. Conversely, this model cannot
be used to test if there is an absolute variation in terms of EF
recovery rate between 2 or several treatments. The sponta-
neous recovery of EF in the CNI rat model should be
considered as one of the major limitations of this model.
5) Several studies in this field lack high quality and correct in vitro
experimental methodology. Describing the various in vitro
techniques in detail is beyond the intent of this ESSM statement;
however, we provided more information on the different avail-
able in vitro methods (such as common stainings and marker
proteins) to assess fibrosis, neural, and endothelial in tissues in
the supplementary data (supplementary data -Table 1)CONCLUSION
Today, the rat is commonly used as an animal model to mimic
post-RP ED by bilaterally crushing the CNs. In this document,
we provided ESSM statements for the correct and reproducible
use of this CNI model. We hope to increase comparability be-
tween reports which could advance the field as a whole. It must
be noted that this model has its limitations. This may help to
narrow the gap between preclinical studies and their translation
in clinical practice.
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